Ferenc Hudecz

Ferenc Hudecz

Auto-generated profile, based on publicly available information

Ferenc Hudecz

Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös Loránd University, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2007 in Peptide Science
Verified
Journal Article
Open access
PDF file
ZMZsanett Miklán
Zsanett Miklán
RSRita Szabó
Rita Szabó
VZVirág Zsoldos‐Mády
Virág Zsoldos‐Mády
JRJudit Reményi
Judit Reményi
ZBZoltán Bánóczi
Zoltán Bánóczi
FHFerenc Hudecz
Ferenc Hudecz
Data reported in this article describe the synthesis of Arg‐rich oligopeptide conjugates of ferrocenecarboxylic acid on solid support with two different strategies and for the first time, the successful preparation of peptide conjugates of ferrocenylacrylic acid in solution. The antitumor effect of conjugates was analyzed by MTT assay in vitro. We demonstrated that ferrocenylacrylic acid possessing an enone (CHCHCO) moiety exhibited remarkable antiproliferative effect against human leukemia cells (HL‐60) in vitro, but its effect was not improved by conjugation with hexa‐ or octaarginines. However, we observed highly increased water‐solubility. In contrast, the results provide evidence that conjugation of ferrocenecarboxylic acid to Argn (n = 6, 8) improved not only its water‐solubility, but also antitumor effect on human leukemia cells in vitro. © 2007 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 88: 108–114, 2007.This article was originally published online as an accepted preprint. The ‘Published Online’ date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.com

16 January 2016 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JPJudit Pozsgay
Judit Pozsgay
FBFruzsina Babos
Fruzsina Babos
KUKATALIN URAY
KATALIN URAY
AMAnna Magyar
Anna Magyar
GGGergő Gyulai
Gergő Gyulai
GSGabriella Sármay
Gabriella Sármay
Autoreactive B cells are crucial players in the pathogenesis of rheumatoid arthritis (RA). Autoantibodies specific for citrullinated proteins (ACPA), present in the serum of approximately 60–70 % of patients, have a pathogenic role in the disease. B cell depleting therapies may result in a transient immunosuppression, increasing the risk of infections. Our aim was to develop a new therapeutic approach to selectively deplete the ACPA producing autoreactive B cells. To target B cells synthetic citrullinated peptide derived from the β chain of fibrin, β60-74Cit 60,72,74 (β60-74Cit), the predominant epitope recognized by ACPA was used. Complement dependent cytotoxicity (CDC) was induced by a modified peptide derived from gp120 of HIV-1. To trigger CDC both the targeting peptide and the complement activating peptide were covalently coupled in multiple copies to the surface of poly (DL-lactic-co-glycolic acid) nanoparticles (NPs). Ex vivo antibody synthesis was examined by ELISA and ELISpot. CDC was tested after dead cell staining by flow cytometry. The β60-74Cit peptide was selectively recognized by a small subset of B cells from RA patients having high level of peptide specific serum antibody, suggesting that the peptide can target diseased B cells. The modified gp120 peptide covalently coupled to NPs induced the formation of the complement membrane attack complex, C5b-9 in human serum. We show here for the first time that bifunctional NPs coupled to multiple copies of both the targeting peptide and the complement activating effector peptide on their surface significantly reduce β60-74Cit peptide specific ex vivo ACPA production, by inducing complement dependent lysis of the citrullinated peptide specific B cells of seropositive RA patients. Bifunctional NPs covalently coupled to autoantigen epitope peptide and to a lytic peptide activating complement may specifically target and deplete the peptide specific autoreactive B-cells.

30 November 2005 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
GSGitta Schlosser
Gitta Schlosser
Gabriella PocsfalviGabriella Pocsfalvi
Gabriella Pocsfalvi
EHEmőke Huszár
Emőke Huszár
AMAntonio Malorni
Antonio Malorni
FHFerenc Hudecz
Ferenc Hudecz

5 October 2011 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
EOErika Orbán
Erika Orbán
MMMarilena Manea
Marilena Manea
AMAndreas Marquadt
Andreas Marquadt
ZBZoltán Bánóczi
Zoltán Bánóczi
GCGabriella Csı́k
Gabriella Csı́k
FHFerenc Hudecz
Ferenc Hudecz

1 April 2007 in Peptides
Verified
Journal Article
Closed access
Gábor MezőGábor Mező
Gábor Mező
ACAndrás Czajlik
András Czajlik
MMMarilena Manea
Marilena Manea
AJAnnamária Jakab
Annamária Jakab
VFViktor Farkas
Viktor Farkas
FHFerenc Hudecz
Ferenc Hudecz

1 January 1996 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
Gábor MezőGábor Mező
Gábor Mező
IMImre Mezö
Imre Mezö
MPMalcolm V. Pimm
Malcolm V. Pimm
JKJudit Kajtár
Judit Kajtár
JSJános Seprödi
János Seprödi
FHFerenc Hudecz
Ferenc Hudecz